Chronomics is an AI-driven platform company that tracks epigenetics for personalized healthcare based in the United Kingdom.
Chronomics uses saliva, which contains buccal epithelial cells and leukocytes, for DNA methylation profiling. Saliva DNA methylation profiles are correlated with those in blood and brain, so saliva can be suedused to capture effects associated with many complex traits. Users are also asked to fill out a lifestyle questionnaire. To interpret their results, users are invited to share their data with Chronomics' team of healthcare professionals, to help provide personalised recommendations to become healthier. Users can test annually to look form health improvements over time.

Chronomics is an AI-driven platform company that tracks epigenetics for personalized healthcare based in the United Kingdom.
Chronomics provides a test that combines Epigenome Sequencing with Machine Learning. The company claims to provideprovides the first actionable epigenetic insights. Chronomics is focused on health, wellbeing and prevention of age and lifestyle related diseases by aiming to monitormonitoring and reducereducing risk factors.
Chronomics uses saliva, which contains buccal epithelial cells and leukocytes, for DNA methylation profiling. Saliva DNA methylation profiles are correlated with those in blood and brain, so saliva can be sued to capture effects associated with many complex traits. Users are also asked to fill out a lifestyle questionnaire. To interpret thiertheir results, users are invited to share their data with Chronomic'sChronomics' team of healthcare professionals, two medical doctors and an epigeneticist, to help provide personalised recommendations to become healthier. Users can test annually to look form health improvements over time.
Chronomics is disrupting DNA testing with epigenetics and AI, with implications for the preventive healthcare revolution coming in the 2020s. They are currently serving private healthcare, innovative practitioners and preventive healthcare programs in major health systems, moving into pharma and biotech, and insurance.